132 related articles for article (PubMed ID: 29624638)
1. Medical management of miscarriage: Predictive factors of success.
Lusink V; Wong C; de Vries B; Ludlow J
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):590-593. PubMed ID: 29624638
[TBL] [Abstract][Full Text] [Related]
2. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage.
Tang OS; Ong CY; Tse KY; Ng EH; Lee SW; Ho PC
Hum Reprod; 2006 Jan; 21(1):189-92. PubMed ID: 16155071
[TBL] [Abstract][Full Text] [Related]
4. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
[TBL] [Abstract][Full Text] [Related]
5. The impact of introducing medical management on conservative and surgical management for early pregnancy miscarriage.
Black KI; de Vries BS; Moses F; Pelosi M; Cong A; Ludlow J
Aust N Z J Obstet Gynaecol; 2017 Feb; 57(1):93-98. PubMed ID: 28251638
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
8. The MISOPRED score: Development and validation of a clinical scoring system to predict the effectiveness of Misoprostol treatment for early pregnancy loss.
Bar-Noy T; Limonad O; Gandelsman E; Shrim A; Sharabi H; Zarecki R; Hallak M; Bruchim I
PLoS One; 2024; 19(5):e0303607. PubMed ID: 38820313
[TBL] [Abstract][Full Text] [Related]
9. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study.
Petersen SG; Perkins A; Gibbons K; Bertolone J; Devenish-Meares P; Cave D; Mahomed K
Aust N Z J Obstet Gynaecol; 2013 Feb; 53(1):64-73. PubMed ID: 23106243
[TBL] [Abstract][Full Text] [Related]
10. Medical Termination of Delayed Miscarriage: Four-Year Experience with an Outpatient Protocol.
Lyra J; Cavaco-Gomes J; Moucho M; Montenegro N
Rev Bras Ginecol Obstet; 2017 Oct; 39(10):529-533. PubMed ID: 28850998
[No Abstract] [Full Text] [Related]
11. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage.
Bagratee JS; Khullar V; Regan L; Moodley J; Kagoro H
Hum Reprod; 2004 Feb; 19(2):266-71. PubMed ID: 14747165
[TBL] [Abstract][Full Text] [Related]
12. The use of misoprostol for early pregnancy failure.
Tang OS; Ho PC
Curr Opin Obstet Gynecol; 2006 Dec; 18(6):581-6. PubMed ID: 17099326
[TBL] [Abstract][Full Text] [Related]
13. The treatment of incomplete miscarriage with oral misoprostol.
Pandian Z; Ashok P; Templeton A
BJOG; 2001 Feb; 108(2):213-4. PubMed ID: 11236122
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
Schreiber CA; Creinin MD; Atrio J; Sonalkar S; Ratcliffe SJ; Barnhart KT
N Engl J Med; 2018 Jun; 378(23):2161-2170. PubMed ID: 29874535
[TBL] [Abstract][Full Text] [Related]
15. Medical management of early pregnancy failure: how to treat and what to expect.
Dempsey A; Davis A
Semin Reprod Med; 2008 Sep; 26(5):401-10. PubMed ID: 18825608
[TBL] [Abstract][Full Text] [Related]
16. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
Chung T; Leung P; Cheung LP; Haines C; Chang AM
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
[TBL] [Abstract][Full Text] [Related]
17. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
[TBL] [Abstract][Full Text] [Related]
18. Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice.
Colleselli V; Schreiber CA; D'Costa E; Mangesius S; Wildt L; Seeber BE
Arch Gynecol Obstet; 2014 Jun; 289(6):1341-5. PubMed ID: 24305748
[TBL] [Abstract][Full Text] [Related]
19. Misoprostol for miscarriages.
Med Lett Drugs Ther; 2013 Mar; 55(1411):19-20. PubMed ID: 23467120
[No Abstract] [Full Text] [Related]
20. Factors related to successful misoprostol treatment for early pregnancy failure.
Creinin MD; Huang X; Westhoff C; Barnhart K; Gilles JM; Zhang J;
Obstet Gynecol; 2006 Apr; 107(4):901-7. PubMed ID: 16582130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
